Evidence map›Paper›PMID 40938244›Full record

ArticleJACC. Case reports2025

Acute Myeloid Leukemia Associated With Catastrophic Arterial and Venous Thrombi.

Nicholas King, Meera Kapadia, Xena Moore, Sophia Khan-Makoid, Elie Mouhayar

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nicholas KingThe University of Texas Health Sciences Center at Houston, Houston, Texas, USA. Electronic address: nicholas.king@uth.tmc.edu.
Meera KapadiaThe University of Texas Health Sciences Center at Houston, Houston, Texas, USA.
Xena MooreThe University of Texas Health Sciences Center at Houston, Houston, Texas, USA.
Sophia Khan-MakoidThe University of Texas Health Sciences Center at Houston, Houston, Texas, USA.
Elie MouhayarThe University of Texas Health Sciences Center, MD Anderson Cancer Center, Houston, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with acute myeloid leukemia (AML) are at increased risk of vascular thrombi due to coagulopathy, however multifocal arterial thrombi are a rare complication. CASE SUMMARY: A 64-year-old man recently diagnosed with AML presented with multifocal arterial and venous thromboses, including aortic thrombi, bilateral pulmonary emboli, and right atrial thrombus, in the absence of overt disseminated intravascular coagulation. He developed acute bilateral limb ischemia requiring above-knee amputation and iliac thrombectomy. Histopathology confirmed leukemic thrombi. Management was complicated by persistent cytopenias, and the patient died during hospitalization. DISCUSSION: Catastrophic thromboembolism manifesting as arterial thrombi without overt disseminated intravascular coagulation is a rare complication of AML, and together with critical limb ischemia carries a poor prognosis. TAKE-HOME MESSAGES: Early management and coordinated multidisciplinary care for arterial and venous thrombi in AML are essential to navigate complex management challenges due to coagulopathy and cytopenias. Optimal treatment strategies remain poorly defined given the limited data.

Indexed as

acute limb ischemiaacute myeloid leukemiaarterial thrombosisvenous thrombosis

Identifiers

PMID40938244
PMCPMC12793871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.